Christian Schultze-Florey

13PUBLICATIONS
66CO-AUTHORS
Gene and molecular therapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 25, 2026
Real-world experience with tabelecleucel within and beyond the approval label.

Kiavasch Mohammad Nejad Farid, Florian Kocher, Tobias Arnold

|Dec 18, 2025
Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden.

Vanja Zeremski, Enver Aydilek, Akhil Behringer

|Apr 16, 2025
Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma.

Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib

|Mar 08, 2025
Anti-CD19 CAR-T cell therapy for acquired hemophilia A.

Christian R Schultze-Florey, Felicitas R Thol, Krasimira Aleksandrova

|Aug 12, 2023
MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML.

Katrin Teich, Michael Stadler, Razif Gabdoulline

|Sep 23, 2022
Healthy-like CD4+ Regulatory and CD4+ Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion.

Jessica Schneider, Leonie Kuhlmann, Yankai Xiao

Pageof 3

Frequent Collaborators

5 joint publications

Christian Koenecke

4 joint publications

Immo Prinz

3 joint publications

Vladan Vucinic

3 joint publications

Ivan Odak